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THE occurrence of hyponatraemia in hypothyroid patients has been well recognised
for many years' and attributed to impaired water excretion2 resulting in dilutional
hyponatraemia. The cause of this association is not well understood, and has been
variously ascribed to relative deficiency of adrenal cortical hormones,3 altered
proximal and distal nephron function,24 structural renal abnormalities,5 6
inappropriate secretion ofantidiuretic hormone (ADH),7'8 increased renal sensitivity
to ADH9 and binding of water by hydrophilic connective tissue ground substance.'0
Apatient with hypothyroidism demonstrating profound hyponatraemia isdescribed,
and a study to establish the prevalence of hyponatraemia in a group of elderly
hypothyroid subjects is summarised.
CASE REPORT
A 73-year-old housewife presented with a 2-3 week history of intermittent pain
and cramps in the calves: she experienced difficulty in walking, and was reported by
relatives to have been increasingly listless and drowsy for several months. She had
attended her general practitioner two years previously with headaches, and was
prescribed amiloride 5 mg and hydrochlorothiazide 50 mg (Moduretic) daily for
hypertension, and advised to avoid adding salt to her diet. This medication was
doubled during the week prior to hospital admission. There was no other relevant
past medical history or family history. On admission she was drowsy and lethargic
with a short attention span, but was fully orientated and responded correctly but
slowly to questions when roused. On examination she was neither dehydrated nor
oedematous, the oral temperature was 95°F, her skin was pale and facial features
puffy but no goitre was palpable. No meningism was elicited, and her speech, visual
fields, optic fundi and discs and pupillary reflexes were normal. There was
generalised symmetrical muscle weakness, with normal tone and preserved
sensation. The tendon reflexes were brisk and easily elicited with a slowed relaxation
component. The plantar responses were flexor. Romberg's sign was not present and
she was unable to walk unaided due to weakness.
The following investigations were performed :- ESR 23 mm in the first hour, Hb
14.0 g, PCV .45, plasma glucose 6.5 mmol/l, urea 5.4 mmol/l, plasma Na 95
mmol/l, K 3.7 mmol/l, Cl 61 mmol/l, Co2 25 mmol/l, total protein 75 g/l, serum
Ca 2.08 mmol/l and phosphate0.36 mmol/l. Pseudohyponatraemia was excluded as
the calculated expected osmolality and the observed plasma osmolality showed no
discrepancy. The Free T4 was <12 pmol/l, TSH 41 mU/l and thyroid microsomal
antibody titre by haemagglutination 25,600, consistent with primary autoimmune
hypothyroidism. The 7 am cortisol was 590 nmol/l and the 10 pm cortisol 525
nmol/l. X-rays of the chest and pituitary fossa were normal. Details of the
electrolyte concentrations in urine and serum are shown in the Figure.
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Clinical and Biochemical Details
THYROXINE 50 microgram/day THYROXINE 100 microgram/day
ORAL SODIUM 30 mmol/day
NORMAL SALINE 300 mmol/day I.V.
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SERUM OSMOLALITY 210 247 273 (normal 280-300 mOsm/kg)
URINE OSMOLALITY 166 366 290 (normal 40-1400 mOsm/kg)
URINARY SODIUM 10 96 120 73 144 (mmol/24 hours)
URINARY POTASSIUM 16 59 20 28 58 (mmol/24 hours)
URINARY UREA 66 38 300 (mmol/24 hours!
URINARY PHOSPHATE 9 21 4 (mmol/24 hours)
URINARY VOLUME 1000 1300 1000 1180 1200 (24 hours)
CREATININE CLEARANCE 46 42 (mis/min)
( t indicates days on which sodium was estimated)
In view of the profound hyponatraemia and hypochloraemia, treatment was
commenced with intravenous 0.9% saline (two litres daily), and her diuretics were
stopped. After biochemical confirmation of hypothyroidism, administration of
thyroxine 50 mcg was commenced 4 days following admission in addition to sodium
chloride 30 mmol daily. The patient's clinical course was characterised by a
fluctuating level ofconsciousness and the development ofmild oedema on the eighth
day which resolved following a single intravenous injection of 40 mg of frusemide.
By the thirteenth day, the patient's clinical condition was stable and improved; on
the fortieth day, the dose of thyroxine was increased to 100 mcg daily. She
subsequently made a complete recovery, returning to full independence.
METHODS AND RESULTS
The results of laboratory investigations in the Belfast City Hospital, recorded on
computer, were searched over a one-year period to identify patients aged 65 years
and over with thyroid function tests consistent with primary hypothyroidism
(Free T4 < 8 pmol/l, TSH . 9 mU/l) and with an accompanying serum electrolyte
measurement within a 7-day period. A total of 82 patients were identified (mean age
77.8, range 66-96 years, 72 female, 10 male), of whom 63 had a normal plasma
sodium concentration (135-145 mmol/l) and 19 had a plasma sodium concentration
less than 135 mmol/l. The mean values of T4 and TSH are recorded in the Table.
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Details ofHypothyroid Survey Patients
Plasma Plasma Plasma Plasma
Age Free TSH Sodium Potassium
No. T4
years pmol/l mU/I mmol/l mmol/l
(range) (range) (range) (range) (range)
Patients with normal
plasma sodium 63 77.4 5.5 26.9 139.6 4.0
(5 male, 58 female) (66-96) (1-8) (9-65) (135-149) (2.1-5.7)
Patients with low
plasma sodium* 19 79.2 4.8 30.2 128.4 4.3
(5 male, 14 female) (67-91) (2-8) (9-50) (95-134) (1.7-7.7)
*Plasma sodium less than 110 mmol/l in 1 patient, less than 120 mmol/l in 1 patient, and less than 130
mmol/l in 6 patients.
The records of the 19 patients with hyponatraemia were searched for possible
contributing factors, and the following were identified: (1) diuretic therapy, which
included frusemide (5 cases), cyclopenthiazide/triamterene (1 case), polythiazide
(1 case), bendrofluazide (1 case), spironolactone in addition to frusemide (2 cases);
(2) diabetes mellitus (2 cases); (3) chronic renal failure (1 case). No contributing
factor other than hypothyroidism was identified in 2 cases.
DISCUSSION
The aetiology of the hyponatraemia in this case report is difficult to unravel.
Factors in favour of a depletional cause for the hyponatraemia include the low salt
intake, the preceding hot summer weather and the diuretic therapy with hydro-
chlorothiazide and amiloride promoting sodium loss from the distal tubule.
However, the patient was not clinically volume-depleted and there was no elevation
of the blood urea or packed cell volume. The presence of satisfactory renal and
normal adrenal function without hypotension and oedema would seem to indicate a
dilutional hyponatraemia due to water retention. The finding of an appropriately
lower urine osmolality than serum osmolality with a low urinary sodium excretion
and improvement with fluid replacement with saline rather than fluid restriction is
not, however, in keeping with a diagnosis of inappropriate ADH secretion, and
suggests a possible structural or functional nephron impairment resulting in water
retention. The markedly lowered serum phosphate, which is normally reabsorbed in
the proximal tubule, indicates that this may be the site of the renal abnormality,
causing an inability to regulate salt and water balance in addition to phosphate, and
resulting in dilutional hyponatraemia. Evidence ofimpaired proximal renal tubular
function in hypothyroidism has been described by Derubertis et al,2 who reported
improvement in distal volume delivery and urine flow after the administration of
acetazolamide. The history, clinical and laboratory findings suggest that this patient
had combined depletional and dilutional hyponatraemia resulting in a plasma
sodium of 95 mmol/l, considerably lower than the values recorded in a 25-year
152review of hyponatraemia myxoedema cases." Her survival and avoidance of
irreversible cerebral oedema and coma supports a slow onset of hyponatraemia
allowing homeostatic adjustments to occur, and similarly favours treatment by slow
sodium replacement with normal saline rather than vigorous hypertonic saline
therapy. While the classical treatment for dilutional hyponatraemia includes fluid
restriction, this was considered inappropriate in view ofthe depletional contribution
to the hyponatraemia. Although the serum sodium rose significantly during the
initial 4 days of treatment with intravenous saline, this was not accompanied by a
dramatic clinical response, and it was not until the thirteenth day after concurrent
treatment with thyroxine and sodium that the patient's condition was stable and
improved. However, the relative importance of sodium and thyroxine treatment
remains conjectural, and it is not possible to confirm the suspected role for
thyroxine in the reversal of the biochemical changes.
The survey of 82 elderly hypothyroid patients demonstrated a low plasma sodium
in 19 (23%/) of cases. Patients with a low plasma sodium had a lower mean Free T4
concentration (4.8 pmol/l) and higher mean TSH concentration (30.2 mU/l) than
the Free T4 concentration (5.4 pmol/l) and mean TSH concentration (26.9 mU/l) of
the patients with a normal plasma sodium concentration. In only 2 of the 19
hyponatraemic patients (11 o) was hyponatraemia considered to be a result of
hypothyroidism alone, while in 14 of the 19 patients (74%), hyponatraemia was
contributed to by diuretic therapy, as has been previously reported.'2 13 These
findings suggest that the combination of diuretic therapy and hypothyroidism may
have a synergistic action on the renal tubule in the elderly, often resulting in a low
plasma sodium, with its attendant mortality and morbidity.", 14
Diuretics should be used with care in elderly patients with untreated hypo-
thyroidism. However, since hypothyroidism mayoftenbedifficult todetect clinically
in the elderly and may remain unrecognised, patients should have careful assessment
of their thyroid status before attributing hyponatraemia solely to diuretic therapy.
I wish to thank Dr. S. G. Welshman for providing the laboratory results, the physicians and surgeons
who allowed access to their patients' records, and Professor R. W. Stout for permission to report the case
and for his helpful advice.
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